Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-000008
Filing Date
2025-01-02
Accepted
2025-01-02 16:08:03
Documents
1
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6019
  Complete submission text file 0000905148-25-000008.txt   7436
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 245 E. 58TH STREET APT #15B NEW YORK NY 10022
Business Address
FRIEDMAN MICHAEL R. (Reporting) CIK: 0001993243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 25502080